Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling: Biophase Distribution, Receptor Theory, and Dynamical Systems Analysis
- 1 February 2007
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 47 (1) , 357-400
- https://doi.org/10.1146/annurev.pharmtox.47.120505.105154
Abstract
Mechanism-based PK-PD models differ from conventional PK-PD models in that they contain specific expressions to characterize, in a quantitative manner, processes on the causal path between drug administration and effect. This includes target site distribution, target binding and activation, pharmacodynamic interactions, transduction, and homeostatic feedback mechanisms. As the final step, the effects on disease processes and disease progression are considered. Particularly through the incorporation of concepts from receptor theory and dynamical systems analysis, important progress has been made in the field of mechanism-based PK-PD modeling. This has yielded models with much-improved properties for extrapolation and prediction. These models constitute a theoretical basis for rational drug discovery and development.Keywords
This publication has 95 references indexed in Scilit:
- Mechanism-Based Pharmacokinetic–Pharmacodynamic Modeling—A New Classification of BiomarkersPharmaceutical Research, 2005
- Modeling and allometric scaling of s(+)‐ketoprofen pharmacokinetics and pharmacodynamics: a retrospective analysisJournal of Veterinary Pharmacology and Therapeutics, 2004
- Physiologically based pharmacokinetics in Drug Development and Regulatory Science: A workshop report (Georgetown University, Washington, DC, May 29–30, 2002)AAPS PharmSci, 2004
- Whole Body Pharmacokinetic ModelsClinical Pharmacokinetics, 2003
- Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Electroencephalogram Effects of GABAA Receptor Modulators: In Vitro-in Vivo CorrelationsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Prediction of Pharmacokinetics Prior to In Vivo Studies. II. Generic Physiologically Based Pharmacokinetic Models of Drug DispositionJournal of Pharmaceutical Sciences, 2002
- Relevance of the Application of Pharmacokinetic-Pharmacodynamic Modelling Concepts in Drug DevelopmentClinical Pharmacokinetics, 1997
- Physiologically based pharmacokinetic modeling as a tool for drug developmentJournal of Pharmacokinetics and Biopharmaceutics, 1995
- Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug DevelopmentThe Journal of Clinical Pharmacology, 1994
- Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarineClinical Pharmacology & Therapeutics, 1979